Structural Basis for Neutralization and Protection by a Zika Virus-Specific Human Antibody
- PMID: 30893607
- DOI: 10.1016/j.celrep.2019.02.062
Structural Basis for Neutralization and Protection by a Zika Virus-Specific Human Antibody
Abstract
We previously reported a human monoclonal antibody, ZK2B10, capable of protection against Zika virus (ZIKV) infection and microcephaly in developing mouse embryos. Here, we report the structural features and mechanism of action of ZK2B10. The crystal structure at a resolution of 2.32 Å revealed that the epitope is located on the lateral ridge of DIII of the envelope glycoprotein. Cryo-EM structure with mature ZIKV showed that the antibody binds to DIIIs around the icosahedral 2-fold, 3-fold, and 5-fold axes, a distinct feature compared to those reported for DIII-specific antibodies. The binding of ZK2B10 to ZIKV has no detectable effect on viral attachment to target cells or on conformational changes of the E glycoprotein in the acidic environment, suggesting that ZK2B10 functions at steps between the formation of the fusion intermediate and membrane fusion. These results provide structural and mechanistic insights into how ZK2B10 mediates protection against ZIKV infection.
Keywords: Zika virus; cryo-EM; crystal structure; domain III; epitope; mechanism; neutralizing antibody; protective antibody.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.
Similar articles
-
Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.J Exp Med. 2020 Feb 3;217(2):e20191792. doi: 10.1084/jem.20191792. J Exp Med. 2020. PMID: 31757867 Free PMC article.
-
Probing Zika Virus Neutralization Determinants with Glycoprotein Mutants Bearing Linear Epitope Insertions.J Virol. 2018 Aug 29;92(18):e00505-18. doi: 10.1128/JVI.00505-18. Print 2018 Sep 15. J Virol. 2018. PMID: 29976678 Free PMC article.
-
Structural Basis of Zika Virus-Specific Antibody Protection.Cell. 2016 Aug 11;166(4):1016-1027. doi: 10.1016/j.cell.2016.07.020. Epub 2016 Jul 27. Cell. 2016. PMID: 27475895 Free PMC article.
-
Zika Virus Envelope Protein and Antibody Complexes.Subcell Biochem. 2018;88:147-168. doi: 10.1007/978-981-10-8456-0_7. Subcell Biochem. 2018. PMID: 29900496 Review.
-
Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure.Virol Sin. 2019 Apr;34(2):168-174. doi: 10.1007/s12250-019-00093-5. Epub 2019 Apr 24. Virol Sin. 2019. PMID: 31020573 Free PMC article. Review.
Cited by
-
Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.J Exp Med. 2020 Feb 3;217(2):e20191792. doi: 10.1084/jem.20191792. J Exp Med. 2020. PMID: 31757867 Free PMC article.
-
How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika.Viruses. 2021 Oct 19;13(10):2106. doi: 10.3390/v13102106. Viruses. 2021. PMID: 34696536 Free PMC article. Review.
-
Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina.Front Virol. 2023;3:1108420. doi: 10.3389/fviro.2023.1108420. Epub 2023 Feb 28. Front Virol. 2023. PMID: 37383986 Free PMC article.
-
Zafirlukast, as a viral inactivator, potently inhibits infection of several flaviviruses, including Zika virus, dengue virus, and yellow fever virus.Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0016824. doi: 10.1128/aac.00168-24. Epub 2024 May 29. Antimicrob Agents Chemother. 2024. PMID: 38809067 Free PMC article.
-
A Peptide-Based Virus Inactivator Protects Male Mice Against Zika Virus-Induced Damage of Testicular Tissue.Front Microbiol. 2019 Sep 27;10:2250. doi: 10.3389/fmicb.2019.02250. eCollection 2019. Front Microbiol. 2019. PMID: 31611865 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases